McNeil AB clinical trials

Formerly part of Johnson & Johnson, Aug 23, 2023 · source ↗

The registry lists 42 studies whose lead sponsor is McNeil AB. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Studies

Recruiting first, then most recently updated. Showing 42 of 42. All Johnson & Johnson studies →

• A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker VolunteersRecruitingNCT07893158Phase 2

  Sponsor listed in the registry: McNeil AB · First submitted after McNeil AB left Johnson & Johnson

• A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study VolunteersWithdrawnNCT05182047Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy VolunteersCompletedNCT04186936Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult VolunteersCompletedNCT03697889Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy SmokersCompletedNCT03259607Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.CompletedNCT03432923Phase 3

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.CompletedNCT03439436Phase 3

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.CompletedNCT03130179Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® MicrotabCompletedNCT01238640Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch TreatmentCompletedNCT00749463Phase 4

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement ProductCompletedNCT01084603Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.CompletedNCT01084707Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Efficacy and Safety of Sinutab on Subjects in the Setting of a Common ColdCompletedNCT00378144Phase 4

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement ProductsCompletedNCT01321931Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Cumulative Skin Irritation Potential of a New 25 mg Nicotine PatchCompletedNCT00967174Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.CompletedNCT01227720Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• To Test Bioequivalence Between Two Tablet Formulations in the Treatment of AllergyCompletedNCT01322282Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• To Test Bioequivalence Between Two Formulations of Paracetamol/PhenylephrineCompletedNCT01112462Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in StoresCompletedNCT01555476Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• An Exploratory Study Comparing Two Nicotine InhalersCompletedNCT01478230Early Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Comparison of Three Medications to Treat Diarrhea in Adults.CompletedNCT00807326Phase 4

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mgCompletedNCT01238627Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Photoirritation and Photoallergic Potential of a New Nicotine PatchCompletedNCT00966901Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.CompletedNCT01234792Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine GumCompletedNCT01368016Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement ProductsCompletedNCT01234896Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Bioequivalence Between Nicotine Replacement Products and Nicorette® GumCompletedNCT01113424Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® GumCompletedNCT01152723Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Pilot Study of a New Nicotine Replacement TherapyCompletedNCT00764439Phase 2

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152749Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152736Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ LozengeCompletedNCT01075659Phase 2

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine GumCompletedNCT00174499Phase 4

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Skin Sensitization Potential of a New Nicotine PatchCompletedNCT00967070Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Study on the Effects of Two Nicotine Replacement Products on Tooth StainingCompletedNCT01440985Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in AdultsCompletedNCT01302093Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference TreatmentsCompletedNCT01316978Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Study to Compare the Pharmacokinetics Profiles of Four Racecadotril ProductsCompletedNCT01476683Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Efficacy and Safety Following Use of a Novel Nicotine Replacement TherapyCompletedNCT00882375Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Cumulative Skin Irritation Potential of a New 15 mg Nicotine PatchCompletedNCT00965913Phase 1

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common ColdCompletedNCT01488604Not applicable

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson

• Smoking Reduction or Cessation With Nicotine Replacement TherapyCompletedNCT00840242Phase 3

  Sponsor listed in the registry: McNeil AB · First submitted before McNeil AB left Johnson & Johnson